BeStock  
Stocks › Biotechnology › OLMA

Olema Pharmaceuticals OLMA

US equityMarket cap rank #3472Biotechnology
$7.02 −$0.13 (-1.82%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $7.02 0.00%
Open$7.01
Prev close$7.15
Day range$6.88 – $7.36
Volume1.26M
Market cap$615.00M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-3.2x
CheapRich

Around its usual level · 54th percentile, 5-year average -4.4x

Price / book1.8x
CheapRich

Around its usual level · 47th percentile, 5-year average 2.1x

#2851 of 5328 stocks by PB (1 = cheapest)

P/E over five years

-21x-14x-7x1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$11.30
Price vs. fair value-37.9%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.80 – 2.06 47% (cheaper than usual) #2851 of 5328 (1 = cheapest)
PE -3.15 -2.13 -4.37 54% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on OLMA.

Sign in to join the discussion.

Scroll to Top